Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
There are currently no FDA-approved disease-modifying therapies that target tau, which, along with amyloid-beta, is a hallmark protein of Alzheimers disease
The extract is rich in polyphenols, flavonoids, and sesquiterpenes that do most of the work in a formula
Recent Developments: 2025: Eli Lilly received FDA approval for tirzepatide (Zepbound) as a treatment for moderate-to-severe obstructive sleep apnea in adults with obesity the first pharmacotherapy approved for this indication expanding tirzepatide's approved uses beyond metabolic conditions into a respiratory indication affecting over 30 million Americans and supported by SURMOUNT-OSA trial data showing 63% reduction in apnea-hypopnea index
Throughout, the labels matter
Nng cc cht in gii cn c duy tr lin tc mc thch hp m bo c th hot ng bnh thng
US$ 28.23
US$ 21.05
US$ 22.05
US$ 29.44
US$ 26.74
US$ 21.31
US$ 28.91
US$ 25.61
